Each year, SynBioBeta hosts the The Global Synthetic Biology Conference to showcase the latest cutting-edge developments in biology that are changing how we solve global problems. As a proud sponsor of this year’s event, we look forward to connecting with the synthetic biology community and sharing our progress toward transforming pharmaceutical supply chains.
A team of Antheia scientists and business leaders – including both co-founders, Dr. Christina Smolke and Dr. Kristy Hawkins – will be in attendance this year, and there are three different sessions throughout the event where attendees can hear from Dr. Smolke.
We also invite you to visit Antheia at Booth #6 to meet our team and learn more about how we leverage synthetic biology to end drug shortages and drive more equitable access to essential medicines.
This year’s event will be held in Oakland, California from May 23 – 25. Be sure to add our three presentations to your conference calendar*: (*all events will be recorded and released on SynBioBeta’s channels after the event)
- Tuesday, May 23 at 4:25-4:35 pm PT: Antheia Spotlight Presentation on Leveraging Synthetic Biology to End Drug Shortages on the Main Stage
- Wednesday, May 24 at 7:30-8:15 am PT: CEO Breakfast Panel with Antheia, Aanika Biosciences, Baruch Future Ventures, MicroByre, and SynBioBeta
- Thursday, May 25 at 1:45-2:30 pm PT: Industry Panel Discussion on Building Resilient Pharma Supply Chains For Accessible Medicines with Dr. Christina Smolke, co-founder and CEO of Antheia, John Nicols, former CEO of Codexis, Cameron Fox, Senior Associate of Luminary Labs, and moderated by Kevin Costa, Associate Director of Content and Communications at Absci.